J. Biochem, 2004, Vol. 135, No. 4 455-463
© 2004 The Japanese Biochemical Society
BIOCHEMISTRY |
Purification and Characterization of Recombinant Human Prostacyclin Synthase
1 Department of Pharmacology, National Cardiovascular Center Research Institute and 2 Division of Microcirculatory Kinetics, Osaka University Graduate School of Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565; 3 Division of Physiology, Institute for Protein Research, Osaka University, Yamada-oka, Suita, Osaka 565-0871; 4 Department of Veterinary Science, Osaka Prefecture University, Sakai, Osaka 599-8531; and 5 Department of Biology, University of Konstanz D-78434, Germany
Prostacyclin synthase (PGIS), which catalyzes the conversion of prostaglandin (PG) H2 to prostacyclin (PGI2), is a member of the cytochrome P-450 (P450) superfamily, CYP8A1. To study the enzymatic and protein characteristics of human PGIS, the enzyme was overexpressed in Spodoptera frugiperda 21 (Sf21) cells using the baculovirus expression system. PGIS was expressed in the microsomes of the infected Sf21 cells after culture in 5 µg/ml hematin-supplemented medium for 72 h. The holoenzyme was isolated from the solubilized microsomal fraction by calcium phosphate gel absorption and purified to homogeneity by DEAE-Sepharose and hydroxyapatite column chromatography. The Km and Vmax values of the purified human PGIS for PGH2 were 30 µM and 15 µmol/min/mg of protein at 24°C, respectively. The optical absorption and EPR spectra of the enzyme revealed the characteristics of a low-spin form of P450 in the oxidized state. The carbon monoxide-reduced difference spectrum, however, exhibited a peak at 418 nm rather than 450 nm. The addition of a PGH2 analogue, U46619, to the enzyme produced an oxygen-ligand type of the difference spectrum with maximum absorption at 407 nm and minimum absorption at 430 nm. Treatment with another PGH2 analogue, U44069, produced a peak at 387 nm and a trough at 432 nm in the spectrum (Type I), while treatment with tranylcypromine, a PGIS inhibitor, produced a peak at 434 nm and a trough at 412 nm (Type II). A Cys441His mutant of the enzyme possessed no heme-binding ability or enzyme activity. Thus, we succeeded in obtaining a sufficient amount of the purified recombinant human PGIS from infected insect cells for spectral analyses that has high specific activity and the characteristics of a P450, indicating substrate specificity.
* To whom correspondence should be addressed. Tel: +81-6-6833-5012 (ext. 2596), Fax: +81-1-6-6872-8090, E-mail: yokoyama{at}jsc.ri.ncvc.go.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Wada, C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al. Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products J. Biol. Chem., August 3, 2007; 282(31): 22254 - 22266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. R. Mbonye, M. Wada, C. J. Rieke, H.-Y. Tang, D. L. DeWitt, and W. L. Smith The 19-amino Acid Cassette of Cyclooxygenase-2 Mediates Entry of the Protein into the Endoplasmic Reticulum-associated Degradation System J. Biol. Chem., November 24, 2006; 281(47): 35770 - 35778. [Abstract] [Full Text] [PDF]
|
|